Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline III Q1 2026 Earnings EPS Surpasses Estimates by 17 as Stock Edges Higher LSF Q1 2026 Earnings Massive EPS Surprise Defies Expectations ALGT Q1 2026 Earnings EPS Surges Past Estimates with 1214 Beat Stock Slips Slightly CPRT Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Lower RPC Inc RES Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Discretion and Share Decline